Skip to main content
. 2021 May 20;137(20):2817–2826. doi: 10.1182/blood.2020007376

Table 4.

All-causality AEs occurring in >10% of all treated patients (N = 51)

AE Grade 1 Grade 2 Grade 3 Grade 4
n % n % n % n %
Diarrhea 17 33 11 22 4 8 0 0
Nausea 20 39 7 14 0 0 0 0
Fatigue 4 8 9 18 0 0 0 0
Insomnia 11 22 2 4 0 0 0 0
Thrombocytopenia 4 8 3 6 4 8 2 4
Headache 9 18 3 6 0 0 0 0
Neutropenia 1 2 2 4 2 4 7 14
Dizziness 8 16 2 4 0 0 0 0
Peripheral edema 8 16 1 2 0 0 0 0
Cough 6 12 2 4 0 0 0 0
Rash 7 14 1 2 0 0 0 0
Rash, maculopapular 8 16 0 0 0 0 0 0
Anemia 1 2 4 8 2 4 0
Arthralgia 5 10 2 4 0 0 0 0
Contusion 7 14 0 0 0 0 0 0
Decreased appetite 5 10 2 4 0 0 0 0
Leukocytosis 0 0 0 0 7 14 0 0
Myalgia 5 10 2 4 0 0 0 0
Pneumonia 0 0 1 2 6 12 0 0
Pyrexia 4 8 2 4 1 2 0 0
Upper respiratory tract infection 4 8 3 6 0 0 0 0
Vomiting 5 10 2 4 0 0 0 0
AST/ALT increase 2 4 2 4 3 6 0 0

AST, aspartate aminotransferase.